OrganiGram Holdings Inc
TSX:OGI

Watchlist Manager
OrganiGram Holdings Inc Logo
OrganiGram Holdings Inc
TSX:OGI
Watchlist
Price: 2.35 CAD 1.73% Market Closed
Market Cap: 315.7m CAD

OrganiGram Holdings Inc
Investor Relations

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. The company is headquartered in Moncton, New Brunswick. The company went IPO on 2011-11-24. Organigram is a licensed producer of cannabis and extract-based products. The firm is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. The company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company’s online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o’ Buds and Trailblazer.

Show more
Loading
OGI
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Dec 16, 2025
AI Summary
Q4 2025

Record Revenue: Organigram delivered record quarterly and full year revenue in fiscal 2025, with Q4 net revenue rising 79% to $80.1 million and full year net revenue up 62% to $259.2 million.

Margin Expansion: Adjusted gross margin reached 38% in Q4 and 35% for the year, both improvements over the prior periods, and management expects further margin gains in 2026.

International Growth: International sales reached a company high of $26.3 million, up 171%, supported by expansion into Germany, the UK, Australia, and the US.

Motif Acquisition: The Motif Labs acquisition drove cost synergies and did not dilute market share, contributing to improved operational leverage.

Guidance Raised: Fiscal 2026 net revenue is expected to exceed $300 million, with further margin and adjusted EBITDA growth and positive free cash flow projected.

Market Leadership: Organigram held the #1 Canadian market share at 11.9% in 2025 and led in most major provinces.

CEO Transition: James Yamanaka will become CEO in early January, bringing international growth experience.

Key Financials
Net Revenue
$80.1 million
Net Revenue
$259.2 million
International Sales
$26.3 million
International Sales
$9.7 million
Adjusted Gross Margin
38%
Adjusted Gross Margin
35%
Adjusted Gross Profit
$30.6 million
Adjusted Gross Profit
$91 million
Adjusted EBITDA
$9.8 million
Adjusted EBITDA
$21.9 million
Net Loss
$38 million
Net Loss
$24.8 million
Free Cash Flow
-$0.7 million
Cash and Short-term Investments
$84.4 million
Unrestricted Cash
$28.2 million
G&A Costs
$17.6 million
G&A Costs
$59.5 million
Selling and Marketing Expenses
$8.9 million
Selling and Marketing Expenses
$31.1 million
SG&A as % of Net Revenue
23% for fiscal 2025
Canadian Market Share
11.9% in fiscal 2025
International Capacity Increase
14,000 kilograms annual increase
CapEx
$17 million in fiscal 2025
Other Earnings Calls

Management

Ms. Beena G. Goldenberg
CEO & Director
No Bio Available
Ms. Helen Martin
Chief Legal Officer & Corporate Secretary
No Bio Available
Mr. Timothy Emberg
Chief Commercial Officer
No Bio Available
Mr. Paolo De Luca C.A., C.F.A
Chief Strategy Officer
No Bio Available
Mr. Greg Guyatt C.A., CPA
Chief Financial Officer
No Bio Available
Ms. Nathalie Batten
Senior Vice President of Operations
No Bio Available
Mr. Geoff Riggs
Chief Information Officer
No Bio Available
Max Schwartz
Director of Investor Relations
No Bio Available
Ms. Megan Amber McCrae
Senior Vice President of Marketing & Communications
No Bio Available
Ms. Katrina May McFadden
Chief People Officer
No Bio Available

Contacts

Address
NEW BRUNSWICK
Moncton
35A English Dr
Contacts
+15063841571.0
www.organigram.ca